Consumer Reports: Alzheimer's drugs are costly, ineffective

01/8/2013 | Washington Post, The

Drugs approved to treat Alzheimer's disease are expensive and are not really effective for many patients, according to Consumer Reports Best Buy Drugs. The report said none of the drugs could be considered a "Best Buy," based on analyses from several health care organizations, and that they had side effects that could be debilitating for older patients.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY